Survivin gene expression in early‐stage non‐small cell lung cancer
- 13 May 2003
- journal article
- research article
- Published by Wiley in The Journal of Pathology
- Vol. 200 (5) , 620-626
- https://doi.org/10.1002/path.1388
Abstract
Survivin is an inhibitor of apoptosis protein, overexpressed in most human malignancies and implicated in mitosis regulation and preservation of cell viability. In order to investigate the prevalence and clinical significance of survivin in early-stage non-small cell lung carcinoma (NSCLC), survivin mRNA levels and protein expression were evaluated, using quantitative real-time RT-PCR and immunohistochemistry, respectively, in a series of 83 patients with stage I (IA and IB) surgically resected NSCLC. Detectable survivin mRNA levels could be demonstrated in all non-neoplastic lung tissue samples and in the tumours analysed. Survivin mRNA levels were elevated in 80 carcinomas (96%) compared to normal lung (p = 0.008). Among all tumours, survivin transcripts were present at a higher level in squamous cell carcinomas (p = 0.0022). Cytoplasmic and nuclear immunoreactivity was found in 70% and 80% of tumours, respectively and both were present in 54%. Cytoplasmic immunoreactivity correlated with tumour stage (p = 0.019). Survivin expression levels did not correlate with patient survival. In one specimen, cytoplasmic and focal nuclear immunostaining was observed in dysplastic bronchial squamous metaplasia. These results document that survivin overexpression is almost always present in early-stage NSCLC, suggesting that this protein may play a role in lung tumourigenesis. This ubiquitous expression makes survivin an appealing new target for novel therapies in lung cancer. In addition, this study also documents that survivin overexpression could be exploited for diagnostic purposes and that quantitative real-time RT-PCR can be a useful tool for evaluating survivin activation in NSCLC. Copyright © 2003 John Wiley & Sons, Ltd.Keywords
This publication has 34 references indexed in Scilit:
- Quantitative analysis of apoptosis‐related gene expression in hepatocellular carcinomaCancer, 2002
- Expression of inhibitors of apoptosis (IAP) proteins in non-small cell human lung cancerZeitschrift für Krebsforschung und Klinische Onkologie, 2002
- Distinct in vivo expression patterns of survivin splice variants in renal cell carcinomasInternational Journal of Cancer, 2002
- Immunohistochemical Localization of Survivin in Benign Cervical Mucosa, Cervical Dysplasia, and Invasive Squamous Cell CarcinomaAmerican Journal of Clinical Pathology, 2002
- CRM1-Mediated Nuclear Export Determines the Cytoplasmic Localization of the Antiapoptotic Protein SurvivinExperimental Cell Research, 2002
- Immunohistochemical Detection of the Anti-Apoptosis Protein, Survivin, Predicts Survival After Curative Resection of Stage II Colorectal CarcinomasAnnals of Surgical Oncology, 2001
- HPV detection and measurement of HPV-16, telomerase, and survivin transcripts in colposcopy clinic patientsJournal of Clinical Pathology, 2001
- Survivin as a Radioresistance Factor in Pancreatic CancerJapanese Journal of Cancer Research, 2000
- Survivin promotes cell proliferation in human hepatocellular carcinomaHepatology, 2000
- Global cancer statisticsCA: A Cancer Journal for Clinicians, 1999